B. Poddevin

Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin.

L. Mir, S. Orlowski, L M Mir, 1994, Biochimica et biophysica acta.

Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.

Y. Pommier, J. Riou, B. Poddevin, 1993, Molecular pharmacology.

Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses.

L. Mir, S. Orlowski, L M Mir, 1992, European cytokine network.

Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture.

L. Mir, S. Orlowski, L M Mir, 1991, Biochemical pharmacology.

Electrochemotherapy of spontaneous mammary tumours in mice.

L. Mir, C. Paoletti, S. Orlowski, 1991, European journal of cancer.

Improved anti-herpes simplex virus type 1 activity of a phosphodiester antisense oligonucleotide containing a 3'-terminal hairpin-like structure.

M. Blumenfeld, S. Meguenni, B. Poddevin, 1994, Antisense research and development.

[Electrochemotherapy, a new antitumor treatment: first clinical trial].

L. Mir, C. Paoletti, S. Orlowski, 1991, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism.

L. Mir, S. Orlowski, L M Mir, 1999, Biochemical pharmacology.

Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations.

L. Mir, J. Belehradek, B. Poddevin, 1990, Biochemical and biophysical research communications.